Vaginal cancer stage ii and drugs of ingredients of diatrizoate meglumine - a phase IV clinical study of FDA data
There is no Vaginal cancer stage ii reported by people who take drugs with ingredients of diatrizoate meglumine yet. This review analyzes which people have Vaginal cancer stage ii with drugs with ingredients of diatrizoate meglumine. It is created by eHealthMe based on reports from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Angiovist 282, Cardiografin, Cystografin, Cystografin dilute, Diatrizoate meglumine, Hypaque-cysto, Reno-30, Reno-60, Reno-dip, Urovist cysto, Urovist cysto pediatric, Urovist meglumine diu/ct.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of diatrizoate meglumine, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ovarian Cysts in Remeron Soltab, how severe and when it was recovered? - 3 seconds ago
- Ciclosporin and Seizures - 7 seconds ago
- Ventolin and Agranulocytosis - 31 seconds ago
- Flolan and Drug Eruption - 34 seconds ago
- Ebrantil and Dementia - a minute ago
- Risedronate Sodium and Parotid Gland Enlargement - a minute ago
- Sandostatin and Protein - Urine - a minute ago
- Sulfacetamide Sodium and Wound Dehiscence - a minute ago
- Magnevist and Adverse Event - a minute ago
- Darvocet-N 100 and Breathing Difficulty - 2 minutes ago